294 related articles for article (PubMed ID: 25743833)
61. Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.
Camargo MC; Piazuelo MB; Mera RM; Fontham ET; Delgado AG; Yepez MC; Ceron C; Bravo LE; Bravo JC; Correa P
Acta Gastroenterol Latinoam; 2007 Dec; 37(4):238-45. PubMed ID: 18254262
[TBL] [Abstract][Full Text] [Related]
62. Chemoprevention of gastric cancer development after
Sugimoto M; Murata M; Yamaoka Y
World J Gastroenterol; 2020 Apr; 26(15):1820-1840. PubMed ID: 32351296
[TBL] [Abstract][Full Text] [Related]
63. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.
Nardone G; Staibano S; Rocco A; Mezza E; D'armiento FP; Insabato L; Coppola A; Salvatore G; Lucariello A; Figura N; De Rosa G; Budillon G
Gut; 1999 Jun; 44(6):789-99. PubMed ID: 10323879
[TBL] [Abstract][Full Text] [Related]
64. Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection?
Guarner J; Bartlett J; Whistler T; Pierce-Smith D; Owens M; Kreh R; Czinn S; Gold BD
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):309-14. PubMed ID: 12960654
[TBL] [Abstract][Full Text] [Related]
65. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
66. Helicobacter pylori infection and precancerous lesions of the stomach.
Valle J; Gisbert JP
Hepatogastroenterology; 2001; 48(42):1548-51. PubMed ID: 11813569
[TBL] [Abstract][Full Text] [Related]
67. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters.
Skopelitou AS; Mitselou A; Katsanos KH; Alexopoulou V; Tsianos EV
Eur J Gastroenterol Hepatol; 2003 May; 15(5):515-23. PubMed ID: 12702909
[TBL] [Abstract][Full Text] [Related]
68. [Helicobacter pylori. Its relationships and morphological controversies].
Vega-Ramos B; Rodríguez-Moguel L
Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):34-40. PubMed ID: 11464620
[TBL] [Abstract][Full Text] [Related]
69. Genetic factors in the development of gastric precancerous lesions--a role of Helicobacter pylori ?
Jablonská M; Chlumská A
J Physiol Paris; 2001; 95(1-6):477-81. PubMed ID: 11595478
[TBL] [Abstract][Full Text] [Related]
70. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.
Watari J; Tanaka A; Tanabe H; Sato R; Moriichi K; Zaky A; Okamoto K; Maemoto A; Fujiya M; Ashida T; Das KM; Kohgo Y
J Clin Pathol; 2007 Aug; 60(8):921-6. PubMed ID: 16997920
[TBL] [Abstract][Full Text] [Related]
71. Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis.
Malik TH; Sayahan MY; Al Ahmed HA; Hong X
J Coll Physicians Surg Pak; 2017 Mar; 27(3):166-172. PubMed ID: 28406776
[TBL] [Abstract][Full Text] [Related]
72. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
73. Cytokine
Negovan A; Iancu M; Tripon F; Crauciuc A; Mocan S; Bănescu C
Int J Med Sci; 2021; 18(12):2743-2751. PubMed ID: 34104107
[No Abstract] [Full Text] [Related]
74. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
[TBL] [Abstract][Full Text] [Related]
75. Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.
Jonaitis L; Ivanauskas A; Janciauskas D; Funka K; Sudraba A; Tolmanis I; Krams A; Stirna D; Vanags A; Kupcinskas L; Leja M; Lin JT
Medicina (Kaunas); 2007; 43(8):623-9. PubMed ID: 17895638
[TBL] [Abstract][Full Text] [Related]
76. [Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication].
Lee Y; Jeon YC; Koo TY; Cho HS; Byun TJ; Kim TY; Lee HL; Eun CS; Lee OY; Han DS; Sohn JH; Yoon BC
Korean J Gastroenterol; 2007 Nov; 50(5):299-305. PubMed ID: 18159161
[TBL] [Abstract][Full Text] [Related]
77. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.
Dixon MF
Gut; 2001 Jul; 49(1):2-4. PubMed ID: 11413099
[No Abstract] [Full Text] [Related]
78. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela.
Kato I; Vivas J; Plummer M; Lopez G; Peraza S; Castro D; Sanchez V; Cano E; Andrade O; Garcia R; Franceschi S; Oliver W; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):468-76. PubMed ID: 15006925
[TBL] [Abstract][Full Text] [Related]
79. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
80. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
